Abstract
INTRODUCTION
Mitral valve repair is the gold standard for treating mitral valve regurgitation; it has a class I recommendation in the 2012 European Society of Cardiology guidelines [1] [2] [3] [4] . However, despite the excellent results achieved with mitral valve repair, some recurrences, socalled failed mitral repairs (FMR), have been reported consistently [5, 6] . It is worth noting that despite extensive data in the literature providing evidence of long-term repair durability, little attention has been devoted to the 'prognostic role' of FMR as an indication for redo mitral valve surgery. Therefore, based on the recent availability of a large multicentre European registry enrolling hundreds of consecutive redo mitral valve operations [7] , our goal was to study this topic in depth. In particular, we (i) reported hospital outcomes of redo mitral valve surgery for FMR in order to provide a 'picture' of the current surgical practice for this indication; (ii) identified factors predicting hospital deaths in the entire population of patients with FMR and in those undergoing isolated redo mitral valve operation for FMR, due to the impact of concurrent surgical procedures on the outcome of redo operations [8] ; (iii) compared propensitymatched populations undergoing redo mitral valve operations for different indications (FMR versus diseased native mitral valves in the context of redo surgery and FMR versus malfunctioning prostheses), in order to further highlight the potential prognostic role of FMR.
METHODS
The purpose and the results of the entire REdo Cardiac Operation Research Database (RECORD) Registry were reported previously [7] . Briefly, 920 consecutive isolated or associated redo mitral valve interventions performed at nine European institutions (Italy, France and Germany) were collected [7] . The only inclusion criterion for enrolment was any type of mitral valve operation performed in patients with a history of prior cardiac surgery. Data related to hospitalization for the index procedure were retrieved from institutional databases and hospital charts [7] . The institutional review board//ethical committee approved the study, but individual patient consent was waived due to the retrospective, observational nature of the study [7] .
Outcome data
The primary end point of the RECORD Registry was operative mortality, defined as all-cause mortality during the index hospitalization (including rehabilitation hospital stay, if discharged to a rehabilitation clinic) or during the first 30 postoperative days (if discharged home) [7] . Secondary end-points were reported previously [7, [9] [10] [11] .
Statistical analysis
Statistical analysis was performed by the SPSS program for Windows, version 13.0 (SPSS Inc, Chicago, IL, USA). Continuous variables are presented as the mean and standard deviation, and categorical variables are presented as counts and percentages. The normal distribution of numerical variables was first assessed by the Shapiro-Wilk normality test. Normally distributed continuous variables were compared using the unpaired t-test, whereas the Mann-Whitney U-test was used for non-normally distributed variables. Categorical variables were analysed using the Chi-square test.
Multivariable analysis identified preoperative covariates that independently predicted operative deaths in the entire population. A stepwise logistic regression with backward selection was used, and the variable FMR was forced into the model to better define the prognostic role of this condition on outcome. Other multivariable analyses with stepwise logistic regression and backward selection were used to determine independent predictors of death in the entire population of patients undergoing redo because of FMR (either with isolated mitral surgery or concomitant procedures), as well as in those undergoing only isolated redo mitral valve operations. Only variables with a P < 0.10 at univariable analysis were included in the regression models to avoid overfitting (Supplementary Table S1 ). Hosmer-Lemeshow's test was used to assess the regression models fit. The area under the receiver operating characteristic curve was used to represent the discriminatory ability of the regression models. Models were expressed in terms of adjusted odds ratio (OR) and 95% confidence interval (CI).
Given the prognostic weight of 'age' in the isolated redo mitral valve operation, its value was also categorized into fifths, based on the definition of quintile cut points to rule out the differential 'weight' on mortality of different age categories.
To reduce the effect of selection bias and potential confounding factors, all the outcome parameters were then adjusted by propensity matching. Accordingly, propensity score models were built using stepwise logistic regression [probability of enter (PE) = 0.20, probability of removal (PR) = 0.10] in order to compare similar cohorts of patients with FMR or diseased native mitral valves and similar cohorts of patients with FMR and malfunctioning prostheses. Variables included in the model, with the corresponding P-values of descriptive statistics and the resulting standardized differences, are reported in Supplementary Table S2 ; P-values > 0. 10 for descriptive statistics with standardized differences < _ 0.2 were considered evidence of non-significant differences between both groups [12] . Forty-six pairs of patients admitted with FMR or native mitral valves and 109 pairs of patients admitted with FMR or a failed mitral prosthesis having the same probability scores (caliper match approximated to three digits) were selected. A P-value of less than 0.05 was considered significant for the entire set of statistical calculations. Table 1 ).
RESULTS

Predictors
Analysis of patients admitted for FMR and determinants of mortality
Of 246 patients with FMR, 137 (55.7%) underwent an isolated redo mitral valve operation, and 109 (44.3%) had a combined redo mitral valve operation plus other cardiac surgical procedures. Severe mitral regurgitation was found in 233 (94.7%) patients, moderate mitral regurgitation in 13 patients (5.3%). The etiology of FMR was found to be endocarditis in 35 patients (14.2%), degenerative disease in 127 (51.6%) and functional disease in 84 (34.1%). The rate of re-repair was limited to 9.3% (23/ 246). Baseline characteristics of the entire FMR population and of patients undergoing an isolated redo mitral valve procedure for FMR are reported in Table 2 . Outcome data of the two groups are otherwise reported in Supplementary Table S2 .
When the entire population of FMR was analysed, 15 variables were associated at univariable analysis with in-hospital deaths (Table 2 ), but only four variables were independent predictors of hospital mortality on multivariable analysis (Table 3 ; area under the receiver operating characteristic curve of the regression model was 0.88; 95% CI = 0.79-0.86, Hosmer-Lemeshow test P = 0.31).
In contrast, 18 variables were associated with death following univariable analysis of patients undergoing an isolated redo mitral valve procedure (Table 2 ), but only three of them were independent predictors of death on multivariable analysis (Table 3; the area under the receiver operating characteristic curve of the regression model was 0.91; 95% CI = 0.86-0.96, HosmerLemeshow test P = 0.71). Given the negative prognostic role of age at surgery after an isolated redo mitral valve operation, this variable was further stratified in fifths. The fourth (> 68 years) and fifth (> _ 73.4 years) quintiles showed a significant impact on hospital deaths [13.8% and 14.8%, respectively, with an OR of 3.8 and 4.2, respectively ( Fig. 1) ].
Analysis of propensity matched populations
Propensity matching was used to nullify potential selection bias related to differences in baseline characteristics between patients with FMR and those with diseased native mitral valves in the context of redo surgery or with a malfunctioning prosthesis (Supplementary Table S3 ).
The resulting 46 pairs of comparable FMRs and diseased native mitral valves in the context of redo surgery showed similar hospital outcomes (Table 4) . On the other hand, 109 comparable pairs of patients with FMR and malfunctioning prostheses demonstrated that the perioperative need for dialysis and transfusions was higher after a redo mitral valve operation for a malfunctioning prosthesis (Table 4) .
DISCUSSION
The leading message of this study, conceived to address the prognostic role of FMR as an indication to perform a redo mitral valve operation, is that FMR per se is not a high-risk condition. This evidence results from the following data: (i) FMR is not an independent predictor of hospital death (P = 0.64) in the RECORD Registry; (ii) FMR shows the lowest hospital mortality rate compared to other indications; (iii) propensity matching analysis demonstrated a similar outcome between FMR and diseased native mitral valves undergoing redo, underscoring that native valves and FMR 'look like each other' from surgical and technical points of view; (iv) FMR has a better outcome than malfunctioning prostheses in propensity-adjusted populations, possibly due to the higher prosthesis-related risk of fragile annuli, infected tissues, calcifications and abscesses [13] .
Indeed, challenging procedures inevitably match with prolonged aortic cross-clamping and cardiopulmonary bypass (CPB) times: the greater need for transfusions and renal replacements found in our failed prostheses population can be easily explained by the direct link between perfusion length and anaemia or acute kidney injury [14, 15] . Likewise, we can interpret the prognostic impact of CPB time on the number of deaths of patients undergoing isolated redo mitral valve operations.
However, despite the good prognosis of mitral valve redo operations for FMR, some high-risk categories that may deserve indepth evaluation before surgery are highlighted in this study. Respiratory comorbidity with Global Initiative for Chronic Obstructive Lung Disease > _ 2 class chronic obstructive pulmonary disease represents a constant risk factor, being highlighted in patients with FMR and in the isolated redo mitral valve subgroup, thus confirming previous findings [7] . Although chronic obstructive pulmonary disease is a preoperative not-modifiable condition, its dramatic odds ratio mandates a careful evaluation before surgical indication, especially in light of the recently available less-invasive techniques (e.g. valve-in-valve implantations) [16] .
Significant systolic dysfunction (left ventricular ejection fraction <30%) and advanced age, especially the eighth decade of life, are highlighted as other high-risk conditions. Although these factors are similarly not-modifiable, both suggest the need of an 'early' surgical indication when the progressive failure of a mitral repair is diagnosed. A poor left ventricular ejection fraction is a wellrecognized negative prognostic factor in both the European Society of Cardiology guidelines and the American College of Cardiology/American Hospital Association guidelines [1, 6] . However, guidelines recommend 'early surgery' preferentially in light of the higher likelihood of repair, whereas we recommend the need of anticipation of surgery because of the poor prognosis associated with advanced age and dysfunctioning ventricles in patients with FMR. Indeed, another reason not to delay surgery in patients with FMR is the good mortality rate (6.5%), 
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particularly in view of the preoperative EuroSCORE II (median 8.7; observed/predicted ratio = 0.75). The occurrence of a major injury to the cardiovascular structures at re-entry is the most important predictor of death (OR 27), coupled with an OR of 7 in the case of injury to the left internal mammary artery-left anterior descending coronary artery. These data agree with those of Morales et al. [17] , highlighting a direct link between iatrogenic lesions at re-entry and massive transfusions due to severe bleeding or myocardial damage due to severe systemic hypotension. These life-threatening complications mandate adequate surgical planning before resternotomy. It is worth noting that preoperative computed tomographic scans and preoperative institution of CPB are infrequent policies within our registry, and they do not predict survival in our series, thus supporting the results of previous literature studies [17] [18] [19] . This finding can be explained by the fact that experienced surgeons performed all the operations collected in the registry, demonstrating how technical skill and surgical experience might have overcome the usefulness of preoperative CT and CPB at our institution. That data are also confirmed by the fact that the incremental number of re-entries do not impact outcome in our cohort, further supporting the concept of 'Heart valve centers of excellence' and 'high-volume centers' [1, 6, 20] . Indeed, we report differences in hospital volumes among the individual centres contributing to the RECORD Registry. However, although previous studies have found a direct link between hospital volume and outcome [21] , we found only a labile association between the participating centre and the mortality rate (given the significant P-value on univariate analysis that was lost on a subsequent multivariate analysis). Indeed, a recent review of the literature on the topic demonstrated that this link is rather weak, concluding that there is not enough evidence to date to support regionalization of mitral valve surgery [22] . One possible explanation of these contradictory findings, perhaps able to explain our labile relationship between hospital volume and outcome, is the demonstration that the surgeon's caseload (not captured in our registry) rather than hospital volume, determines in-hospital outcome after mitral valve surgery [23] . Finally, it should be emphasized that previous studies demonstrated excellent results after redo mitral valve surgery with minimally invasive right thoracotomy and endoscopic view, given the lower than predicted mortality rate and the strong degree of patient satisfaction [24] . Avoidance of extensive surgical dissection, optimal valve exposure and lower transfusion requirements are reported as additional advantages with these techniques [25] . Unfortunately, because we do not collect alternative surgical access sites for re-entry (e.g. different types of thoracotomy, ministernotomy), we cannot speculate on this topic, even though several centres reported that these routes are safer access sites for redo operations [24, 25] .
Limitations and strengths of the study
The retrospective nature of the information in our registry and the heterogeneity in surgical strategies and perioperative care among the participating institutions may have limited the results of this study. The absence of alternative surgical approaches to conventional resternotomy also might have limited the weight of this study. Absence of echocardiographic data related to left ventricular diameters and volumes at surgery is another limitation. Finally, the precise surgical anatomy at the redo operation is not captured in detail because of the retrospective nature of the registry, thus limiting potential conclusions on re-repair rates and related speculations. However, other surrogate factors directly linked with the surgical anatomy (e.g. endocarditis, type of endocarditis, etiology, degree of mitral regurgitation at surgery, LVEF, urgent/emergent procedures, number of mitral valve redo operations) were collected and analysed accordingly.
Nevertheless, the observational multicentre nature of the registry provides a 'real world' picture of current redo mitral valve practices at different European institutes. Moreover, this is the first multicentre study specifically suggesting the outcome of FMR as a potential surgical indication based on results from hundreds of redo mitral valve patients.
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